IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:IPN - FR0010259150 - Common Stock
122.7 EUR
+1.6 (+1.32%)
Overall IPN gets a fundamental rating of 6 out of 10. We evaluated IPN against 53 industry peers in the Pharmaceuticals industry. While IPN has a great health rating, its profitability is only average at the moment. IPN may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make IPN suitable for value investing!
1. Profitability
1.1 Basic Checks
IPN had positive earnings in the past year.
IPN had a positive operating cash flow in the past year.
Each year in the past 5 years IPN has been profitable.
Each year in the past 5 years IPN had a positive operating cash flow.
1.2 Ratios
IPN has a Return On Assets of 6.56%. This is comparable to the rest of the industry: IPN outperforms 56.60% of its industry peers.
The Return On Equity of IPN (10.59%) is comparable to the rest of the industry.
IPN's Return On Invested Capital of 14.88% is fine compared to the rest of the industry. IPN outperforms 77.36% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IPN is in line with the industry average of 13.94%.
The last Return On Invested Capital (14.88%) for IPN is above the 3 year average (12.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
IPN has a Profit Margin (11.91%) which is comparable to the rest of the industry.
IPN's Profit Margin has declined in the last couple of years.
The Operating Margin of IPN (26.01%) is better than 64.15% of its industry peers.
IPN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 83.32%, IPN belongs to the top of the industry, outperforming 90.57% of the companies in the same industry.
IPN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IPN is creating value.
IPN has more shares outstanding than it did 1 year ago.
IPN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, IPN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.47 indicates that IPN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.47, IPN is in the better half of the industry, outperforming 64.15% of the companies in the same industry.
The Debt to FCF ratio of IPN is 1.69, which is an excellent value as it means it would take IPN, only 1.69 years of fcf income to pay off all of its debts.
IPN has a Debt to FCF ratio of 1.69. This is amongst the best in the industry. IPN outperforms 88.68% of its industry peers.
IPN has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IPN (0.20) is better than 77.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.47 |
ROIC/WACC1.9
WACC7.83%
2.3 Liquidity
A Current Ratio of 1.98 indicates that IPN should not have too much problems paying its short term obligations.
IPN has a better Current ratio (1.98) than 71.70% of its industry peers.
A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.80, IPN belongs to the top of the industry, outperforming 81.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.24% over the past year.
Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
Looking at the last year, IPN shows a quite strong growth in Revenue. The Revenue has grown by 9.45% in the last year.
The Revenue has been growing slightly by 5.83% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
IPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.58% yearly.
IPN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.58% yearly.
EPS Next Y9.37%
EPS Next 2Y3.92%
EPS Next 3Y4.54%
EPS Next 5Y5.58%
Revenue Next Year8.6%
Revenue Next 2Y6.18%
Revenue Next 3Y6.04%
Revenue Next 5Y4.58%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.95, the valuation of IPN can be described as very reasonable.
Based on the Price/Earnings ratio, IPN is valued a bit cheaper than 79.25% of the companies in the same industry.
IPN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.56.
The Price/Forward Earnings ratio is 11.06, which indicates a very decent valuation of IPN.
IPN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IPN is cheaper than 77.36% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.79. IPN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.95 | ||
| Fwd PE | 11.06 |
4.2 Price Multiples
96.23% of the companies in the same industry are more expensive than IPN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 66.04% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.94 | ||
| EV/EBITDA | 5.71 |
4.3 Compensation for Growth
IPN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)1.27
PEG (5Y)1.36
EPS Next 2Y3.92%
EPS Next 3Y4.54%
5. Dividend
5.1 Amount
IPN has a Yearly Dividend Yield of 1.15%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.83, IPN has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 1.87, IPN is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
25.90% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
IPN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP25.9%
EPS Next 2Y3.92%
EPS Next 3Y4.54%
EPA:IPN (12/15/2025, 3:38:05 PM)
122.7
+1.6 (+1.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.21%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap10.28B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts68.89
Price Target131.89 (7.49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.12%
PT rev (3m)2.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.5%
EPS NY rev (3m)7.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)1.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.95 | ||
| Fwd PE | 11.06 | ||
| P/S | 2.74 | ||
| P/FCF | 19.94 | ||
| P/OCF | 11.46 | ||
| P/B | 2.43 | ||
| P/tB | 7.7 | ||
| EV/EBITDA | 5.71 |
EPS(TTM)10.27
EY8.37%
EPS(NY)11.09
Fwd EY9.04%
FCF(TTM)6.15
FCFY5.01%
OCF(TTM)10.71
OCFY8.72%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.27
PEG (5Y)1.36
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.47 |
F-Score7
WACC7.83%
ROIC/WACC1.9
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y9.37%
EPS Next 2Y3.92%
EPS Next 3Y4.54%
EPS Next 5Y5.58%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.6%
Revenue Next 2Y6.18%
Revenue Next 3Y6.04%
Revenue Next 5Y4.58%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year41.46%
EBIT Next 3Y13.73%
EBIT Next 5Y7.89%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
Can you provide the valuation status for IPSEN?
ChartMill assigns a valuation rating of 7 / 10 to IPSEN (IPN.PA). This can be considered as Undervalued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for IPSEN?
The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 9.37% in the next year.
Can you provide the dividend sustainability for IPN stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.